In today’s briefing:
- Entero Healthcare Pre-IPO – Has Been Scaling up Rapidly Aided by a Flurry of Acquisitions
- Aspira Women’s Health, Inc. – Provides Important Update on EndoCheck Diagnostic Test
Entero Healthcare Pre-IPO – Has Been Scaling up Rapidly Aided by a Flurry of Acquisitions
- Entero Healthcare Solutions Limited (2294842D IN) is looking to raise US$200m in its upcoming India IPO. The IPO will consist of both a primary and secondary component.
- Entero Healthcare Solutions (Entero) is a healthcare products distributor in India.
- In this note, we look at the company’s past performance.
Aspira Women’s Health, Inc. – Provides Important Update on EndoCheck Diagnostic Test
- Aspira Women’s Health announced today that it has completed the design of the EndoCheck test based on the analysis of samples received from The University of Oxford in October.
- This data shows EndoCheck to be a high-performing blood test for localized endometriosis, including ovarian endometriosis masses known as endometrioma.
- Endometrioma is a localized form of endometriosis that has formed an ovarian mass. It is one of the most common types of endometriosis.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
